Improving medication verification for cancer patients: a pragmatic AI driven population health study

Applications are invited for a three-year PhD studentship. The studentship will start on 1 October 2021.

Apply

To apply please use the online application form. Simply search for PhD Applied Health Studies, then clearly state that you are applying for a PhD studentship and name the project at the top of your personal statement.

Online application

Before applying, please ensure you have read the Doctoral College’s general information on applying for a research degree.

For more information on the admissions process please contact doctoralcollege@plymouth.ac.uk.

This fully funded PhD studentship is based at the University of Plymouth’s Centre for Health Technology, a leading international research group focused on the design, development and implementation of health technology innovations in health and care. This vibrant team of researchers work within the intersection of digital health, software engineering, data science, clinical artificial intelligence, and innovation strategy, with a primary aim to create a global hub for technology incubation in the South West of the United Kingdom.


Project description

Medication errors, including those in prescribing, dispensing, or administration of a drug, are the single most preventable cause of patient harm. They have a significant impact on the efficiency of the workflow in pharmacy, raise safety concerns for patients, and result in a financial burden on the healthcare systems. Within cancer treatment, emphasis on reducing the number of medication errors has been an active research area for many years, with understanding that interdisciplinary approaches are vital to assure continuous improvement. Opportunities created by the reduction of transaction times for complex computational processes and use of machine learning to support clinical decision making, create a potential catalyst for the development of tools for reduction in medication errors.

This PhD studentship offers an exciting opportunity of exploring AI and machine learning with large clinical data sets residing within electronic health records to create methods to assure the effective use of systemic anticancer treatment (including traditional cytotoxic chemotherapy, immunotherapy, novel oral therapies etc.) without compromising patient safety. The studentship will require application of interdisciplinary skills to enable cooperation between the research, clinical, industry and patient communities in the development of a novel approach which could enhance clinical outcomes.


Supervision team

Professor Shang-Ming Zhou (Google Scholar link)

Dr Edward Meinert (Google Scholar link)

Mrs Andrea Preston Andrea.Preston@uhbw.nhs.uk

This PhD student will be academically advised by Professor Shang-Ming Zhou and Dr Edward Meinert, research scientists with research interests in applied artificial intelligence and machine learning, and computing science in health and care. The student will also be advised by Mrs Andrea Preston, a Macmillan Divisional Lead Haematology and SW Cancer Commissioning Pharmacist. This supervision team will assure the execution of a world-class PhD embedded into the wider digital health ecosystem at the University of Plymouth.


Eligibility

This PhD studentship is offered for UK and international applicants. It is supported for 3 years and includes full Home or International tuition fees, plus a stipend of £15,609 per annum (2021/22 rate).

Applicants should have:

  • A first or upper second-class honours degree, and a relevant Master’s qualification in Computing Science, Data Science, Statistics, Health Informatics, Medical Informatics, Bioinformatics, or any areas related;
  • Interest in working with real-world problems and large data sets;
  • Excellent proficiency in English and outstanding communication skills;
  • Strong analytical and programming skills;
  • A “can do”, positive attitude with an aspiration to change the world.
  • Experience in machine learning is advantageous.
  • Experience in publication of peer-reviewed literature is desirable.

International applicants should meet the English language requirements, please see the details from the University’s English language requirements webpage. IELTS Academic 6.5 or above (or equivalent) with 5.5 in each individual category is commonly required by the University’s Doctoral College.

A research proposal is required. Please see our applicants and enquirers page for a list of supporting documents to upload with your application.


Enquiry

If you wish to discuss this project further informally, please contact Professor Shang-Ming Zhou (shangming.zhou@plymouth.ac.uk), Dr Edward Meinert (edward.meinert@plymouth.ac.uk), or Mrs Andrea Preston (Andrea.Preston@uhbw.nhs.uk).

For more information on the admissions process generally, please contact doctoralcollege@plymouth.ac.uk.


Closing date

The closing date for applications is 30 July 2021. Shortlisted candidates will be invited for interview in August. We regret that we may not be able to respond to all applications. Applicants who have not received a response within six weeks of the closing date should consider their application has been unsuccessful on this occasion